Home > Income Statement > NATCO PHARMA

NATCO PHARMA
Revenue

    Back to Income Statement
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
AD     Remove this Ad

NATCO PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹4,430 Cr₹3,999 Cr₹2,707 Cr₹1,945 Cr₹2,052 Cr

What is the latest Revenue of NATCO PHARMA ?

The latest Revenue ratio of NATCO PHARMA is ₹4,430 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹4,430 Cr
Mar2024₹3,999 Cr
Mar2023₹2,707 Cr
Mar2022₹1,945 Cr
Mar2021₹2,052 Cr

How is Revenue of NATCO PHARMA Trending?

Years Revenue % Change
Mar2025 ₹4,430 Cr
10.77
Mar2024 ₹3,999 Cr
47.72
Mar2023 ₹2,707 Cr
39.20
Mar2022 ₹1,945 Cr
-5.23
Mar2021 ₹2,052 Cr -

Compare Revenue of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹15,135.7 Cr -1% -7.2% -29.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,991.0 Cr 0.1% -3.2% -2.6% Stock Analytics
DIVIS LABORATORIES ₹162,371.0 Cr -1.5% -7.3% 2.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,229.0 Cr -1.3% -0.7% 24.4% Stock Analytics
CIPLA ₹108,441.0 Cr 1.5% -8.1% -6.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,407.0 Cr 3.2% 5.6% 3.1% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-1%

-7.2%

-29.2%

SENSEX

2.9%

-1.1%

8.5%


You may also like the below Video Courses